TABLE 2

Mean relative change in mRNA expression, protein levels, and in situ enzyme activity in hepatocytes cultured at different conditions compared with control (ECM overlay, 0.01 μM DEX)

The same donor preparations (n = 3) were used for all of the tested conditions. An analysis of mRNA expression and enzyme activity was performed after 4 days in culture and protein after 5 days, respectively. P450 and UGT proteins were determined from microsomal fractions, and transporter proteins were determined from plasma membrane preparations of hepatocyte cultures.

Target0.1 μM DEXCollagen ISingle Gel
mRNAProteinActivitymRNAProteinActivitymRNAProteinActivity
CYP1A21.581.931.080.741.640.700.530.620.68
CYP2A63.002.280.381.450.290.45
CYP2B61.010.930.390.780.270.77
CYP2C81.271.121.150.751.240.710.490.600.60
CYP2C91.131.470.980.661.530.490.510.820.75
CYP2C190.960.800.930.751.430.710.770.790.74
CYP2D61.191.340.591.600.440.70
CYP2E10.952.200.492.020.360.98
CYP3A4*1.761.531.660.330.700.570.320.730.88
CYP3A43
CYP3A51.510.560.63
CYP3A70.8216.160.426.850.970.92
CYP4A110.740.890.521.010.530.75
P450 reductase
UGT1A11.041.450.681.480.640.89
UGT1A41.000.620.65
UGT1A61.250.900.90
UGT1A91.110.620.73
UGT2B70.801.030.571.370.651.46
UGT2B150.540.780.91
Na/K-ATPase1.451.921.02
γ-GTP3.877.646.99
β-actin1.001.001.00
ABCA80.890.571.040.940.820.63
MDR11.420.381.110.691.270.64
MDR30.440.490.67
BSEP1.390.670.490.740.350.66
MRP10.670.350.722.291.040.53
MRP21.190.530.940.630.590.51
MRP3
MRP4
MRP50.791.553.61
MRP60.750.490.79
BCRP1.170.890.810.900.590.92
ABCG81.380.340.830.510.660.41
NTCP1.170.840.730.870.580.62
OAT20.751.040.75
OCT11.920.960.620.690.390.53
OATP1B30.670.940.511.030.510.89
OATP2B11.060.931.041.210.650.74
OATP1B10.761.040.970.950.570.84
CNT10.310.630.47
ENT10.410.940.60
MCT10.540.650.63
MATE11.550.570.640.800.790.65
Na/K-ATPase0.700.580.79
γ-GTP0.630.790.94
β-actin1.001.001.00
  • * CYP3A4 protein was determined indirectly by CYP3A4 = CYP3A4/CYP3A43 − CYP3A43.